Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Asset Writedowns and Impairment (2020 - 2025)

Selectis Health's Asset Writedowns and Impairment history spans 7 years, with the latest figure at $106763.0 for Q3 2025.

  • For Q3 2025, Asset Writedowns and Impairment fell 87.36% year-over-year to $106763.0; the TTM value through Sep 2025 reached $340752.0, down 86.95%, while the annual FY2024 figure was $1.0 million, 61.85% down from the prior year.
  • Asset Writedowns and Impairment for Q3 2025 was $106763.0 at Selectis Health, down from $136348.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $1.6 million in Q4 2023 and bottomed at -$8001.0 in Q2 2021.
  • The 5-year median for Asset Writedowns and Impairment is $252050.0 (2022), against an average of $335813.9.
  • The largest annual shift saw Asset Writedowns and Impairment plummeted 113.97% in 2021 before it soared 3568.45% in 2022.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $869263.0 in 2021, then tumbled by 33.18% to $580830.0 in 2022, then surged by 169.58% to $1.6 million in 2023, then plummeted by 100.13% to -$1967.0 in 2024, then soared by 5527.71% to $106763.0 in 2025.
  • Per Business Quant, the three most recent readings for GBCS's Asset Writedowns and Impairment are $106763.0 (Q3 2025), $136348.0 (Q2 2025), and $99608.0 (Q1 2025).